FdaApplication
NDA 215833
Identifiers
- fda_app_no: NDA215833
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2022-03-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PLUVICTO | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN | 27mCi/ML | SOLUTION;INTRAVENOUS |
1 product